1009-0460
2013 Issue 8
Clinical efficacy of glutamine for the prevention and treatment of acute radiation-induced diarrhea
GU Wendong;PEI Honglei;HUANG Jin;XI Dan;CHEN Yuan;WEI Jun
GU Wendong;PEI Honglei;HUANG Jin;XI Dan;CHEN Yuan;WEI Jun
..............page:737-739
Analysis of intensity-modulated radiotherapy for untreated patients with nasopharyngeal carcinoma
TANG Jianmin;MA Xiumei;HOU Yanli;DAI Liyan;CAO Hongbin;YE Ming;BAI Yongrui
TANG Jianmin;MA Xiumei;HOU Yanli;DAI Liyan;CAO Hongbin;YE Ming;BAI Yongrui
..............page:699-703
The expression and clinical significance of survivin and Ki-67 in non-hodgkin's lymphoma in oral and maxillofacial region
LIU Zhuoxing;LIU Wenling
LIU Zhuoxing;LIU Wenling
..............page:695-698
Clinicopathological features of primary hepatic malignant vascular tumors: A analysis on 41 cases
ZHAO Qian;LIU Haiping;XIAN Zhihong;LU Xinyuan;DONG Hui;CONG Wenming
ZHAO Qian;LIU Haiping;XIAN Zhihong;LU Xinyuan;DONG Hui;CONG Wenming
..............page:718-722
Clinical observation of neoadjuvant chemotherapy with docetaxel plus lobaplatin regimen in triple negative breast cancer
YAO Yufeng;GONG Jianping;TANG Jinhai;QIN Jianwei
YAO Yufeng;GONG Jianping;TANG Jinhai;QIN Jianwei
..............page:723-725
Progression of metronomic chemotherapy on inducing tumor dormancy
QIAO Jingjing;XIN Yan
QIAO Jingjing;XIN Yan
..............page:750-754
Levels of CEA, CA125 and CA19-9 in postoperative peritoneal fluid drainage of colorectal cancer and their clinical significance
ZHUANG Xiaoquan;ZHAO Yong;XIANG Beiting;WANG Jianyun;XU Ting
ZHUANG Xiaoquan;ZHAO Yong;XIANG Beiting;WANG Jianyun;XU Ting
..............page:734-736
Clincopathological analysis of hepatic epithelioid hemangioendothelioma
ZHOU Mei;LI Jingying;BAI Jingping;ZHAO Feng;WANG Cuicui
ZHOU Mei;LI Jingying;BAI Jingping;ZHAO Feng;WANG Cuicui
..............page:746-749
Clinical observation on XELOX regimen as systemic chemotherapy for advanced primary liver carcinoma
yang liu qing ; qin shu zuo ; hua hai qing ; gong xin lei ; liu xiu feng ; xia zhao ; chen ying xia ; wang lin
yang liu qing ; qin shu zuo ; hua hai qing ; gong xin lei ; liu xiu feng ; xia zhao ; chen ying xia ; wang lin
..............page:704-708
Preliminary study of the effects of β-elemene on breast cancer stem cells in cell line MCF-7/ADM
LI Luan;DONG Yan;WANG Ling;GAO Yajie
LI Luan;DONG Yan;WANG Ling;GAO Yajie
..............page:683-687
Clinical observation of CT-guided 125Ⅰ seed implantation on refractory metastatic liver cancer
LI Baoguo;GUO Zhi;WANG Haitao;ZHANG Weihao
LI Baoguo;GUO Zhi;WANG Haitao;ZHANG Weihao
..............page:713-717
Clinical observation of lobaplatin used for intracavitary instillation on malignant pleuroperitoneal cavity hydrops
TIAN Xin;ZHANG Zhenyong;WU Lina;WU Rong
TIAN Xin;ZHANG Zhenyong;WU Lina;WU Rong
..............page:740-742
Progress in relationship between EZH2 and gastric cancer
ZHANG Qi;SHEN Lili;CHEN Jinfei
ZHANG Qi;SHEN Lili;CHEN Jinfei
..............page:755-759
Research of methylation of the LINE-1 promoter in peripheral plasma of hepatocellular carcinoma
gao xu dong ; qu jian hui ; he yan ; guan xue ; feng fan ; wang chun ping ; lu yin ying ; bai wen lin ; wang zuo
gao xu dong ; qu jian hui ; he yan ; guan xue ; feng fan ; wang chun ping ; lu yin ying ; bai wen lin ; wang zuo
..............page:679-682
Prognostic value of positive lymph node ratio in colorectal cancer
LI Qinggang;QIAN Wenbiao;HU Xiaocui;LIU Dan
LI Qinggang;QIAN Wenbiao;HU Xiaocui;LIU Dan
..............page:730-733
Clinical study of recombinant anti-tumor and anti-virus protein injection compared with placebo in metastatic colorectal cancer after failure of second-line and more than second-line treatment
mao xiao yang ; wang yan ; lin li ; xu nong ; xiong jian ping ; bai li ; shen lin ; liu wei ; xu jian ming
mao xiao yang ; wang yan ; lin li ; xu nong ; xiong jian ping ; bai li ; shen lin ; liu wei ; xu jian ming
..............page:673-678
jia zu xing man xing lin ba xi bao bai xue bing 3 li
wang tao ; zheng yong guang ; li yu min
wang tao ; zheng yong guang ; li yu min
..............page:768
xi tuo xi dan kang yin qi shen bing zong he zheng 1 li
cheng ying ; hua hai qing ; qin shu zuo
cheng ying ; hua hai qing ; qin shu zuo
..............page:766-767
Expression of miR-122 in hepatocellular carcinoma and its relationship with cell cycle regulation
ZHANG Ying;JIA Shaochang;XIANG Fang;LU Lei;WANG Xuan
ZHANG Ying;JIA Shaochang;XIANG Fang;LU Lei;WANG Xuan
..............page:691-694
Prevention and treatment progress of tumor-associated venous thromboembolism
DENG Yi;CHEN Xiaopin
DENG Yi;CHEN Xiaopin
..............page:760-765
Expression of EML4-ALK in non-small cell lung cancer and its clinical significance
WANG Meng;YANG Jiyuan;LI Junchuan;CHEN Yanxuan
WANG Meng;YANG Jiyuan;LI Junchuan;CHEN Yanxuan
..............page:688-690
Comparison of the clinical effect in patients with resectable esophageal cancer after esophagectomy followed by gastric tube or whole stomach reconstruction
LI Yong;WANG Huayong;WANG Lei;WANG Gaoming;GAO Peng
LI Yong;WANG Huayong;WANG Lei;WANG Gaoming;GAO Peng
..............page:743-745
Comparison of pemetrexed plus cisplatin regimen and vinorelbine plus cisplatin regimen as the first-line treatment of advanced non-small cell lung cancer
GENG Chunyan;CAI Wei;CHEN Bin
GENG Chunyan;CAI Wei;CHEN Bin
..............page:726-729
Clinical observation of forty-three advanced hepatocellular carcinoma patients treated with sorafenib
WANG Nanya;ZHAO Hengjun;HE Hua;MIAO Fenghua;CUI Guozhen;LI Wei
WANG Nanya;ZHAO Hengjun;HE Hua;MIAO Fenghua;CUI Guozhen;LI Wei
..............page:709-712